We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+4.31%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$877M
AUM Growth
+$37M
Cap. Flow
+$5.06M
Cap. Flow %
0.58%
Top 10 Hldgs %
46.42%
Holding
614
New
48
Increased
198
Reduced
134
Closed
49

Sector Composition

Rank Sector Weight
1 Financials 5.52%
2 Technology 5.13%
3 Healthcare 5.07%
4 Industrials 4.07%
5 Consumer Discretionary 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHG icon
226
Philips
PHG
$26.1B
$129K 0.01%
3,654
-51
-1% -$1.74K
TFCFA
227
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$128K 0.01%
2,772
-116
-4% -$5.32K
STI
228
DELISTED
SunTrust Banks, Inc.
STI
$127K 0.01%
1,902
+276
+17% +$19.7K
AMP icon
229
Ameriprise Financial
AMP
$48.8B
$125K 0.01%
846
+278
+49% +$39.8K
VCSH icon
230
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$124K 0.01%
1,590
TIP icon
231
iShares TIPS Bond ETF
TIP
$14.7B
$122K 0.01%
1,103
+103
+10% +$11.5K
BIB icon
232
ProShares Ultra NASDAQ Biotechnology
BIB
$86.2M
$121K 0.01%
1,730
TXN icon
233
Texas Instruments
TXN
$261B
$117K 0.01%
1,095
TTE icon
234
TotalEnergies
TTE
$190B
$116K 0.01%
165,475
CFG icon
235
Citizens Financial Group
CFG
$30.6B
$115K 0.01%
2,980
+149
+5% +$6.01K
ONB icon
236
Old National Bancorp
ONB
$10.2B
$115K 0.01%
5,981
SBUX icon
237
Starbucks
SBUX
$120B
$115K 0.01%
2,024
-773
-28% -$40.9K
IBB icon
238
iShares Biotechnology ETF
IBB
$9.71B
$112K 0.01%
916
+16
+2% +$1.88K
SLB icon
239
SLB Ltd
SLB
$75B
$112K 0.01%
1,844
+1
+0.1% +$64
CCI icon
240
Crown Castle
CCI
$32.2B
$109K 0.01%
980
+6
+0.6% +$668
JPUS
241
JPMorgan Diversified Return US Equity ETF
JPUS
$465M
$108K 0.01%
1,446
+129
+10% +$9.52K
MDY icon
242
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$100K 0.01%
270
-2
-0.7% -$732
RDS.A
243
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$100K 0.01%
1,474
ARE icon
244
Alexandria Real Estate Equities
ARE
$8.56B
$98K 0.01%
776
+4
+0.5% +$506
VNLA icon
245
Janus Henderson Short Duration Income ETF
VNLA
$3.35B
$97K 0.01%
1,935
+9
+0.5% +$451
JLL icon
246
Jones Lang LaSalle
JLL
$16.7B
$96K 0.01%
663
APTV icon
247
Aptiv
APTV
$10.3B
$95K 0.01%
1,136
+280
+33% +$25.6K
RWX icon
248
State Street SPDR Dow Jones International Real Estate ETF
RWX
$270M
$95K 0.01%
2,475
EZU icon
249
iShare MSCI Eurozone ETF
EZU
$9.91B
$94K 0.01%
2,300
-7,150
-76% -$296K
IWM icon
250
iShares Russell 2000 ETF
IWM
$81.9B
$94K 0.01%
557
-91
-14% -$15.4K

Similar funds

Capital Analysts LLC's Q3 2018 Portfolio in Review

As of Q3 2018, Capital Analysts LLC held 614 positions worth $877M, up 4.4% from $840M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Capital Analysts LLC's Q3 2018 filing shows 48 new, 198 increased, 134 reduced and 49 closed positions. Its largest new stake was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 244,339 shares worth $8.14M. The largest sale was iShares 5-10 Year Investment Grade Corporate Bond ETF, an estimated $7.54M.

By sector, the portfolio is most concentrated in Financials at 5.5% of assets, down from 5.6% a quarter earlier, followed by Technology and Healthcare.

  • Capital Analysts LLC's largest Q3 2018 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 244,339 shares worth $8.14M.
  • Capital Analysts LLC added most to Vanguard Total International Bond ETF in Q3 2018, an estimated $5.89M increase.
  • Capital Analysts LLC's biggest Q3 2018 reduction was iShares 5-10 Year Investment Grade Corporate Bond ETF, cutting an estimated $7.54M.
  • Capital Analysts LLC fully exited Masco in Q3 2018, selling an estimated $2.6M.
  • Capital Analysts LLC's ten largest holdings make up 46% of its $877M portfolio in Q3 2018.
  • Capital Analysts LLC opened 48 new positions and closed 49 in Q3 2018.
  • Capital Analysts LLC's portfolio value rose 4.4% quarter-over-quarter to $877M.

Based on Capital Analysts LLC's 13F filing for Q3 2018, filed 7 Nov 2018.